AI and Blockchain: A Powerful Convergence for Innovation The convergence of AI and blockchain is revolutionizing technology by combining blockchain’s security and transparency with AI’s data processing power. This synergy enables smarter, decentralized applications, enhances automation, and ensures data integrity, unlocking new opportunities for innovation in sectors like finance, healthcare, and supply chain management. Visit our blog for more insights! https://www.apptunix.com/blog/the-convergence-of-ai-and-blockchain-development/

Blockchain App Development for Supply Chain Management Blockchain App Development for Supply Chain Management focuses on creating transparent, secure, and efficient systems that enhance visibility across the supply chain. By leveraging decentralized technology, these apps streamline tracking, authentication, and transactions, reduce fraud, and optimize operations, ensuring reliable data flow and improved collaboration among stakeholders for better decision-making. Visit more info: https://www.apptunix.com/blockchain-development-company/

Building #decentralized digital identities for the world. Use #NFT #domains as your. Universal username across apps and websites. Join now: https://zigi.link/UnstoppableDomains Payment address for #wallets and much more! https://zigilink.com/RFAWJ

DESPACE is a comprehensive decentralized social media. Get it here: https://zigi.link/p2pb2b DSE is a utility token with following usages in the DESPACE ecosystem. https://zigilink.com/EJkFf

DESPACE is a comprehensive decentralized social media. Get it here: https://zigi.link/p2pb2b DSE is a utility token with following usages in the DESPACE ecosystem. https://zigilink.com/EJkFf

Monkeypox Treatment market Analysis and Trends by 2022-2035 The recent rise in the incidence of the monkeypox disease, also known as Mpox, has compelled both industry players and regional government authorities to undertake active initiatives in order to control the spread of the disease Roots Analysis is pleased to announce the publication of its recent study, titled, “Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits, 2023-2035” The study features an extensive study of the current market landscape and future opportunity for the players focused on the development of monkeypox therapeutics, vaccines and diagnostic kits. Amongst other elements, the report features:  A general introduction to monkeypox virus, along with information on signs and symptoms of the disease, history of monkeypox outbreaks and details on transmission of disease from animals to humans and humans to humans.  A detailed assessment of the current market landscape of monkeypox therapeutics / vaccines that are approved / under development, based on several relevant parameters.  A detailed assessment of the current market landscape of monkeypox diagnostic kits, based on several relevant parameters.  A product competitiveness analysis of the Mpox diagnostic kits, based on supplier power and product competitiveness.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in monkeypox therapeutics / vaccines and diagnostic kits domain.  An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2018-2022 (till October).  An in-depth analysis on various grants, received since the year 2003, by players engaged in this field.  A detailed analysis of more than 200 peer-reviewed, scientific articles related to research on monkeypox therapeutics / vaccines and diagnostic kits, during the period of 2018-2022 (till September).  A qualitative analysis to understand the five competitive forces under an insightful Porter's Five Forces framework.  A detailed market forecast for monkeypox therapeutics / vaccines and diagnostic kits, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Product  Therapeutics  Vaccines  Developer  Bavarian Nordic  Emergent BioSolutions  KM Biologics  SIGA Technologies  Type of Kit  Polymerase Chain Reaction (PCR) Detection Kits  Antigen Detection Kits  Antibody Detection Kits  Type of End User  Hospitals and Clinics  Diagnostic Laboratories  Other End Users  Key Geographical Regions  North America (US and Canada)  Europe (UK, France, Germany, Spain, Italy, Rest of EU)  Asia-Pacific (Japan and Australia)  Rest of the World  Transcripts of interviews held with the following senior level representatives of stakeholder companies:  Willy Tozoke Laou Man Cheong (Business Director, Hunan Runmei Gene Technology)  John W Sharkey (Vice President, Business Development, GeoVax)  Horace Lee (Sales Manager, Firegene)  Alan Yu (Sales Manager, Hangzhou Testsea Biotechnology) Key companies covered in the report  Bavarian Nordic  Emergent BioSolutions  ACON Laboratories  altona Diagnostics  DNA Software  Elabscience  Goldsite Diagnostics  Hangzhou Testsea Biotechnology  Jiangsu Bioperfectus Technologies  Lansion Biotechnology To view more details on this report, click on the link https://www.rootsanalysis.com/reports/monkeypox-treatment-market.html You may also be interested in the following titles: Decentralized Clinical Trials / Virtual Clinical Trials Market Global Antibiotics Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #MonkeypoxTreatmentMarket #MonkeypoxTreatmentMarketGrowth #Monkeypox #mpox #Monkeypoxtreatment

Decentralized, secure, Immutable, non-counterfeitable and interoperable digital money. Join now: https://zg.ink/pitagor"

Modular facilities Manufacturers market, Size and Share by 2035 Modular facilities can be an effective way for drug developers and manufacturers to reduce costs, minimize delays, and expedite time-to-market, by utilizing the available infrastructure while operating in accordance with the standard GMP guidelines The financial opportunity within modular facilities market has been analyzed across the following segments:  Size of Facility  Small Plants  Mid-sized Plants  Large Plants  Very Large Plants  Type of Industry Served  Pharmaceutical  Biotechnology  Type of Modular Construct  Hybrid Skid Modular Constructs  Plug-and-Play Modular Constructs  Skid-Mounted Modular Constructs  Truckable Modular Constructs  Others Modular Constructs  Type of Construction Component  Process Equipment  Base Building  Mechanical, Electrical and Plumbing System  Process Commodities  Other Construction Components  Type of Facility  Manufacturing  Aseptic Filling  Research and Development  Others  Scale of Operation  Clinical  Commercial  Type of Product  Cell and Gene Therapies  Vaccines  Biosimilars  Monoclonal Antibodies  Advanced Pharmaceuticals  Sterile Products  Viral Vectors  Other Products  Type of Expansion  New Facilities  Facility Expansions  Planned Expansions  Type of Modular Construction  Relocatable  Permanent  Type of Material  Steel  Wood  Concrete  Key Geographical Regions  North America  Europe  Asia  Middle East and North Africa (MENA)  Rest of the world The Modular Facilities in the Pharmaceutical and Biotech Market, 2023-2035, report features the following companies, which we identified to be key players in this domain:  Cytiva  G-CON Manufacturing  Germfree  IPM Technologies  KeyPlants  ModuleCo Pharma  NNE  Pharmadule Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: Modular Facility Manufacturers 5. Market Landscape: Modular Cleanroom Providers 6. Modular Facility Manufacturers: Company Competitiveness Analysis 7. Company Profiles 8. Partnerships and Collaborations 9. Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry 10. Facility Construction Trends in the Pharmaceutical Industry 11. Cost, Time Optimization Framework 12. Market Forecast 13. Prevalent and Emerging Trends 14. Future Growth Opportunities 15. Conclusion 16. Executive insights 17. Appendix I: Tabulated data 18. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/modular-manufacturing-market/178.html You may also be interested in the following titles: Cannabis Testing Market Decentralized Clinical Trials / Virtual Clinical Trials Market You may also like to learn what our experts are sharing in Roots educational series: mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Novel Cell Cytometers: Need of the Hour About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #ModularfacilitiesManufacturersMarketTrends #Modularfacilities #ManufacturersMarketGrowth #OffsiteConstruction #PrefabricatedBuildings #TemporaryBuildings

Building #decentralized digital identities for the world. Use #NFT #domains as your. Universal username across apps and websites. Website URL. Payment address for #wallets. and much more! Join now: https://zigi.link/UnstoppableDomains #domains https://zigilink.com/GCnnc

DESPACE is a comprehensive decentralized social media. Get it here: https://zigi.link/p2pb2b DSE is a utility token with following usages in the DESPACE ecosystem. https://zigilink.com/gIXbB